WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer

Go to the profile of Hao Fan
Hao Fan
Dr, Shanghai Changhai Hospital
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

Share with...

...or copy the link

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

Nature
Nature Nature

WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer - npj Precision Oncology

npj Precision Oncology - WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer

The protein tyrosine phosphatase SHP2 plays a key role in activating RAS signaling, but its inhibitors are widely resistant in colorectal cancer (CRC). We reveal WWP1-PTEN-AKT signaling pathway is involved in the resistance of SHP2 inhibition. Combined inhibition of WWP1 and SHP2 exerts a synergistic lethal effect in CRC cells. Expression levels of WWP1 and SHP2 contribute to prognostic modeling in CRC patients. These findings may assist in individual clinical decision-making and clinical trial design, especially for patients with KRAS-mutant CRC.

Go to the profile of Hao Fan
Hao Fan
Dr, Shanghai Changhai Hospital

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Sign In Register

Follow the Topic

Gastrointestinal Cancer
Life Sciences > Biological Sciences > Cancer Biology > Cancers > Gastrointestinal Cancer
Pharmacy
Life Sciences > Health Sciences > Pharmacy
Molecular Biology
Life Sciences > Biological Sciences > Molecular Biology

Related Collections

With Collections, you can get published faster and increase your visibility.

Emerging adjuvant and neo-adjuvant treatment approaches in solid tumors

This Collection aims to explore the latest advancements, research findings, and clinical applications of adjuvant and neo-adjuvant treatment approaches in solid tumors.

Publishing Model: Open Access

Deadline: Dec 30, 2025

Explore this Collection

AI agents in oncology

This Collection explores AI agents in oncology, including autonomous and multimodal systems for clinical decision-making, workflow automation, reasoning and their trustworthiness.

Publishing Model: Open Access

Deadline: Feb 20, 2026

Explore this Collection

Recommended Content

Cookies

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.

Further information can be found in our privacy policy.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.